USTR to improve its "Special 301" IP review
This article was originally published in Scrip
The US government says it hopes to cut the losses that intellectual property (IP)-based companies incur through breaches of IP rights in US trading partner countries with new measures aimed at improving the office of the US Trade Representative's "Special 301" review.
You may also be interested in...
Brazil’s medicines regulator, ANVISA, finally has a new set of rules for the evaluation and marketing authorization of advanced therapy medicines.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.